Cutler Group’s Chemed CHE Stock Holding History

Cutler Group’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-1,000	Closed	-$4K	–	6674
2016 Q1	$4K	Buy	1,000 +500	+100%	+$67.6K	﹤0.01%	5010
2015 Q4	$5K	Buy	+500	New	+$73.9K	﹤0.01%	4860

Other funds holding CHE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

GAMCO Investors Greenwich, Connecticut $11.1B AUM 41.79% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return

Cutler Group's CHE Position: Q2 2017 in Review

Cutler Group sold out of Chemed (CHE) in Q2 2017, closing a stake of 374 shares — an estimated $68K sold.

Cutler Group first reported a position in CHE in Q1 2016 and held it in 3 quarters. The position peaked at $68K in Q1 2017. 272 funds tracked by Wall St. Rank hold CHE as of Q2 2017.

Cutler Group reported no remaining Chemed position as of Q2 2017 after selling out during the quarter.
Cutler Group sold 374 Chemed shares in Q2 2017, an estimated $68K.
Cutler Group first reported a position in Chemed in Q1 2016 and held it in 3 quarters.
Cutler Group's Chemed position peaked at $68K in Q1 2017.
272 funds tracked by Wall St. Rank held Chemed as of Q2 2017.

Based on Cutler Group's 13F filing for Q2 2017, filed 11 Jul 2017.